Search Results - "Kale, Arundhati S."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center by Michael, Mini, Minard, Charles G., Kale, Arundhati S., Brewer, Eileen D.

    Published in Pediatric transplantation (01-02-2016)
    “…Minimizing IS to reduce side effects without compromising long‐term renal transplant survival is the goal of all IS protocols. We conducted a retrospective…”
    Get full text
    Journal Article
  3. 3

    Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease by Sheth, Rita D., Brandt, Mary L., Brewer, Eileen D., Nuchtern, Jed G., Kale, Arundhati S., Goldstein, Stuart L.

    Published in Kidney international (01-11-2002)
    “…Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Transplantation is the optimal therapy for pediatric…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease by Lerner, Gary, Kale, Arundhati S, Warady, Bradley A, Jabs, Kathy, Bunchman, Timothy E, Heatherington, Anne, Olson, Kurt, Messer-Mann, Louise, Maroni, Bradley J

    Published in Pediatric nephrology (Berlin, West) (01-11-2002)
    “…Darbepoetin alfa is a novel erythropoiesis-stimulating protein with a two- to threefold longer half-life than recombinant human erythropoietin (epoetin) in…”
    Get full text
    Journal Article
  5. 5

    Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose by Chishti, Aftab S., Sorof, Jonathan M., Brewer, Eileen D., Kale, Arundhati S.

    Published in American journal of kidney diseases (01-10-2001)
    “…Cyclosporine (CsA) has been successfully used for treatment of children with focal segmental glomerulosclerosis (FSGS) and nephrotic syndrome (NS) for the last…”
    Get full text
    Journal Article
  6. 6

    Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis by Sheth, Rita D., Kale, Arundhati S., Brewer, Eileen D., Brandt, Mary L., Nuchtern, Jed G., Goldstein, Stuart L.

    Published in American journal of kidney diseases (01-09-2001)
    “…Semipermanent venous catheters remain the most commonly used access for chronic hemodialysis (HD) in pediatric patients. The recent availability of Tesio…”
    Get full text
    Journal Article
  7. 7

    Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis by SOROF, J. M, HAWKINS, E. P, BREWER, E. D, BOYDSTUN, I. I, KALE, A. S, POWELL, D. R

    Published in Pediatric nephrology (Berlin, West) (01-11-1998)
    “…In patients with proteinuria, African-American (AA) ethnicity is reported to be a risk factor for focal segmental glomerulosclereosis (FSGS) and its…”
    Get full text
    Conference Proceeding Journal Article
  8. 8
  9. 9

    Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate by KALE, A. S, LIU, F, HINTZ, R. L, BAKER, B. K, BREWER, E. D, LEE, P. D. K, DURHAM, S. K, POWELL, D. R

    Published in Pediatric nephrology (Berlin, West) (01-08-1996)
    “…Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the intravascular space before acting on…”
    Get full text
    Conference Proceeding Journal Article
  10. 10
  11. 11